In a landmark decision, cannabis has been rescheduled from Schedule 1 to Schedule 3, marking a significant shift in federal policy. Previously classified under Schedule 1, cannabis was grouped with drugs considered to have no accepted medical use and a high potential for abuse. This reclassification to Schedule 3, which includes substances that have a lower potential for abuse and are recognized for medical use, represents a pivotal change in how cannabis is regulated at the federal level.